Yao Pharma
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A pharma company developing novel small molecule therapies for metabolic and cardiovascular disorders.
Metabolic DiseaseCardiovascular Disease
Technology Platform
Focuses on medicinal chemistry and small molecule drug discovery for validated and novel targets in metabolic and cardiovascular pathways.
Opportunities
Leveraging the vast and growing patient population for metabolic diseases in China and globally to commercialize improved therapeutic options.
Risk Factors
Extremely high barriers to entry and competition from established, highly effective drugs that are becoming generic, making market penetration difficult.
Competitive Landscape
Enters the extremely crowded and competitive metabolic/cardiovascular drug market, requiring significant differentiation to compete against blockbuster drugs from global pharma leaders.